female
neuroleptic malignant syndrome
methylphenidate
defects
supratentorial
basal ganglia
striatum
multicystic encephalomalacia
severe
perinatal
hypoxic-ischemic encephalopathy
predisposing factor
neuroleptic malignant syndrome
dopaminergic blockade
mechanism
pathogenesis
syndrome
methylphenidate
dopamine agonist
inhibition
dopamine
dopaminergic systems
brainstem
midbrain
spinal cord
syndrome
gamma-aminobutyric acid-ergic deficiency
diazepam
gamma-aminobutyric acid-mimetic agent
patient
neuroleptic malignant syndrome
methylphenidate
